These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15032312)

  • 1. Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.
    DeGraw RT; Anderson BD
    Pharm Res; 2004 Feb; 21(2):300-8. PubMed ID: 15032312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Drug Metab Dispos; 1996 Oct; 24(10):1155-61. PubMed ID: 8894519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
    DeGraw RT; Anderson BD
    Pharm Res; 2001 Sep; 18(9):1270-6. PubMed ID: 11683239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
    Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral absorption of anti-aids nucleoside analogues: 3. Regional absorption and in vivo permeability of 2',3'-dideoxyinosine in an intestinal-vascular access port (IVAP) dog model.
    Sinko PJ; Sutyak JP; Leesman GD; Hu P; Makhey VD; Yu H; Smith CL
    Biopharm Drug Dispos; 1997 Nov; 18(8):697-710. PubMed ID: 9373726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.
    Roth JS; McCully CM; Balis FM; Poplack DG; Kelley JA
    Drug Metab Dispos; 1999 Oct; 27(10):1128-32. PubMed ID: 10497138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cardiotoxicity of the Anti-HIV dideoxynucleoside, F-ddA, in the rat.
    Donzanti BA; Kelley JA; Tomaszewski JE; Roth JS; Tosca P; Placke M; Singer A; Yarrington JT; Driscoll JS
    Fundam Appl Toxicol; 1995 Sep; 27(2):167-76. PubMed ID: 8529811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination intestinal metabolism and permeability for several compounds in rats. Implications on regional bioavailability in humans.
    Sinko PJ; Hu P
    Pharm Res; 1996 Jan; 13(1):108-13. PubMed ID: 8668657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which 2',3'-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy.
    Gibbs JE; Jayabalan P; Thomas SA
    J Neurochem; 2003 Feb; 84(4):725-34. PubMed ID: 12562517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection.
    Hartman NR; Yarchoan R; Pluda JM; Thomas RV; Marczyk KS; Broder S; Johns DG
    Clin Pharmacol Ther; 1990 May; 47(5):647-54. PubMed ID: 2111751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of D-glucose in the rat studied using in situ intestinal perfusion: a permeability-index approach.
    Wang Y; Aun R; Tse FL
    Pharm Res; 1997 Nov; 14(11):1563-7. PubMed ID: 9434275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.
    Srinivas NR; Shyu WC
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):329-34. PubMed ID: 10892896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cultured cerebral capillary endothelial cells in modeling the central nervous system availability of 2',3'-dideoxyinosine.
    Johnson MD; Anderson BD
    J Pharm Sci; 2000 Mar; 89(3):322-35. PubMed ID: 10707013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of new anti-HIV agents: 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    Russell JW; Klunk LJ
    Biochem Pharmacol; 1989 May; 38(9):1385-8. PubMed ID: 2497744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in mice.
    el Dareer SM; Tillery KF; Kalin JR; Hill DL
    Invest New Drugs; 1989 Jul; 7(2-3):139-46. PubMed ID: 2507472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.